Mylan Pharmaceuticals is voluntarily recalling 20,780 bottles of Dymista (azelastine hydrochloride and fluticasone propionate) Nasal Spray. The recall was initiated because of the potential presence of foreign substance glass fragments in the neck area of the glass bottles. This prescription-only medication is used for treating allergy symptoms, and approximately 20,780 bottles are included in this nationwide recall.
If glass fragments are present in the bottle, there is a risk that they could be inhaled or cause physical injury to the nasal passage during use. No specific injuries have been reported in the available data, but the presence of foreign glass in a nasal spray poses a mechanical safety hazard.
Contact healthcare provider and return to pharmacy.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.